TSE:OR - Osisko gold royalties Stock Price, Forecast & News

Osisko gold royalties' stock was trading at C$9.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OR shares have increased by 7.5% and is now trading at C$10.60. View which stocks have been mosted impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Osisko gold royalties in the last year. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Osisko gold royalties.

Osisko gold royalties is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Osisko gold royalties.

Osisko gold royalties Ltd (TSE:OR) posted its quarterly earnings results on Wednesday, February, 19th. The company reported $0.07 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.07. The company earned $51.03 million during the quarter, compared to analysts' expectations of $31 million. View Osisko gold royalties' earnings history.

Osisko gold royalties declared a quarterly dividend on Monday, March 30th. Investors of record on Wednesday, April 15th will be paid a dividend of 0.05 per share on Wednesday, April 15th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.89%. The ex-dividend date of this dividend is Monday, March 30th. View Osisko gold royalties' dividend history.

7 analysts have issued 1 year price targets for Osisko gold royalties' stock. Their forecasts range from C$15.00 to C$19.25. On average, they anticipate Osisko gold royalties' stock price to reach C$16.28 in the next twelve months. This suggests a possible upside of 53.6% from the stock's current price. View analysts' price targets for Osisko gold royalties.

News headlines about OR stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Osisko gold royalties earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutOsisko gold royalties.

Some companies that are related to Osisko gold royalties include B2Gold (BTO), Saracen Mineral (SAR), Detour Gold (DGC), Yamana Gold (YRI), B2Gold (BTG), Alamos Gold (AGI), SSR Mining (SSRM), Centerra Gold (CG), NovaGold Resources (NG), Novagold Resources (NG), Centamin (CEE), Endeavour Mining (EDV), Regis Resources (RRL), West Fraser Timber (WFT) and ALACERGOLD/IDR UNRESTR (AQG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Osisko gold royalties investors own include SLS International (SLS), Immunomedics (IMMU), Suncor Energy (SU), Royal Gold (RGLD), Sandstorm Gold (SSL), Agnico Eagle Mines (AEM), First Majestic Silver (FR), Alio Gold (ALO), Xilinx (XLNX) and Visa (V).

Osisko gold royalties trades on the Toronto Stock Exchange (TSX) under the ticker symbol "OR."

Shares of OR and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

One share of OR stock can currently be purchased for approximately C$10.60.

Osisko gold royalties has a market capitalization of C$1.67 billion and generates C$392.60 million in revenue each year. Osisko gold royalties employs 40 workers across the globe. View additional information about Osisko gold royalties.

The official website for Osisko gold royalties is http://osiskogr.com/.

Osisko gold royalties' mailing address is Suite 300 1100, Avenue des Canadiens-de-Montreal, MONTREAL, QC H3B 2S2, Canada. The company can be reached via phone at +1-514-9400670.